AC Immune (ACIU) Other Gross PP&E Adjustments (2016 - 2025)
AC Immune (ACIU) reported Other Gross PP&E Adjustments of -$5.7 million for Q4 2025, up 8.48% year-over-year from -$5.2 million in Q4 2024, and up 2.35% on a QoQ basis from -$5.8 million in Q3 2025.
AC Immune (ACIU) has 9 years of Other Gross PP&E Adjustments data on file, last reported at -$5.7 million in Q4 2025.
- Quarterly Other Gross PP&E Adjustments rose 8.48% year-over-year to -$5.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$5.7 million (up 8.48% YoY) and the FY2025 annual result came in at -$5.5 million, up 11.77% from the prior year.
- Other Gross PP&E Adjustments grew to -$5.7 million in Q4 2025 per ACIU's latest filing, from -$5.8 million in the prior quarter.
- Across five years, Other Gross PP&E Adjustments topped out at -$2.6 million in Q3 2022 and bottomed at -$4.0 billion in Q4 2023.
- The 5-year median for Other Gross PP&E Adjustments is -$4.8 million (2025), against an average of -$765.5 million.
- The widest annual swing landed in 2021, when Other Gross PP&E Adjustments sank 139704.44%; it then jumped 99.91% in 2022.
- Tracing ACIU's Other Gross PP&E Adjustments over 5 years: stood at -$3.2 billion in 2021, then jumped by 99.91% to -$2.9 million in 2022, then tumbled by 135580.19% to -$4.0 billion in 2023, then soared by 99.84% to -$6.2 million in 2024, then grew by 8.48% to -$5.7 million in 2025.
- Per Business Quant, the three latest ACIU Other Gross PP&E Adjustments figures stand at -$5.7 million (Q4 2025), -$5.8 million (Q3 2025), and -$6.0 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Gross PP&E Adjustments (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -83,048.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -60,691.22 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -285.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -892,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -1.69 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -189.30 Mn |
| 10 | AC Immune | 325.88 Mn | 211.53 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -5.68 Mn |
| Dec 31, 2025 | -5.68 Mn |
| Sep 30, 2025 | -5.82 Mn |
| Sep 30, 2025 | -5.82 Mn |
| Jun 30, 2025 | -5.95 Mn |
| Jun 30, 2025 | -5.95 Mn |
| Mar 31, 2025 | -5.77 Mn |
| Mar 31, 2025 | -5.77 Mn |
| Dec 31, 2024 | -6.21 Mn |
| Dec 31, 2024 | -6.21 Mn |
| Sep 30, 2024 | -3.57 Mn |
| Sep 30, 2024 | -3.57 Mn |
| Jun 30, 2024 | -3.58 Mn |
| Jun 30, 2024 | -3.58 Mn |
| Mar 31, 2024 | -3.83 Mn |
| Mar 31, 2024 | -3.83 Mn |
| Dec 31, 2023 | -3.95 Bn |
| Dec 31, 2023 | -3.95 Bn |
| Sep 30, 2023 | -2.72 Mn |
| Sep 30, 2023 | -2.72 Mn |
| Jun 30, 2023 | -2.82 Mn |
| Jun 30, 2023 | -2.82 Mn |
| Mar 31, 2023 | -2.89 Mn |
| Mar 31, 2023 | -2.89 Mn |
| Dec 31, 2022 | -2.91 Mn |
| Dec 31, 2022 | -2.91 Mn |
| Sep 30, 2022 | -2.58 Mn |
| Sep 30, 2022 | -2.58 Mn |
| Jun 30, 2022 | -2.73 Mn |
| Jun 30, 2022 | -2.73 Mn |
| Mar 31, 2022 | -3.00 Mn |
| Mar 31, 2022 | -3.00 Mn |
| Dec 31, 2021 | -3.16 Bn |
| Dec 31, 2021 | -3.16 Bn |
| Sep 30, 2021 | -2.80 Bn |
| Sep 30, 2021 | -2.80 Bn |
| Jun 30, 2021 | -2.96 Bn |
| Jun 30, 2021 | -2.96 Bn |
| Mar 31, 2021 | -2.37 Bn |
| Mar 31, 2021 | -2.37 Bn |
| Dec 31, 2020 | -2.46 Mn |
| Dec 31, 2020 | -2.46 Mn |
| Sep 30, 2020 | -2.10 Mn |
| Sep 30, 2020 | -2.10 Mn |
| Jun 30, 2020 | -2.12 Mn |
| Jun 30, 2020 | -2.12 Mn |
| Mar 31, 2020 | -2.22 Mn |
| Mar 31, 2020 | -2.22 Mn |
| Dec 31, 2019 | -2.28 Mn |
| Dec 31, 2019 | -2.28 Mn |
| Sep 30, 2019 | -1.92 Mn |
| Sep 30, 2019 | -1.92 Mn |
| Jun 30, 2019 | -1,972.68 |
| Jun 30, 2019 | -1,972.68 |
| Mar 31, 2019 | -2.09 Mn |
| Mar 31, 2019 | -2.09 Mn |
| Sep 30, 2017 | 4.94 Mn |
| Sep 30, 2017 | 4.94 Mn |
| Dec 31, 2016 | 3.09 Mn |
| Dec 31, 2016 | 3.09 Mn |